close

Strike action from Thursday 27 June to Tuesday 2 July 2024

Junior doctors at The Christie will strike from 7am on Thursday 27 June until 7am on Tuesday 2 July 2024.

We are proactively contacting patients with appointments that may be affected. If you have an appointment on any of these dates, please continue to come to The Christie and our other centres as planned, unless we contact you to tell you otherwise. Please do not call to check if your appointment is still going ahead.

Skip to Content

CAR-T (Chimeric Antigen Receptors Cell Therapy)

CAR-T involves removing immune cells. The process then modifies them in a laboratory to recognise cancer cells.

Immune cells, called T-cells, are taken from a sample of the patient’s blood. They are then reprogrammed in the lab to recognise and destroy the patient’s cancer cells. This ’living therapy’ is then given to the patient.

In 2019, The Christie joined a group of 9 NHS hospitals approved to provide Chimeric Antigen Receptors Cell Therapy (CAR-T) for adults with large B-cell lymphoma and acute lymphoblastic leukaemia for children and young people up to the age of 25.

The Christie is pleased to announce this product as a standard of care and also for clinical trials. We have been treating patients with these cells since April 2019. 

If you have any queries about our CAR-T therapy services, please email: the-christie.cart@nhs.net

Last updated: March 2023

© 2024 The Christie NHS Foundation Trust